Back

Use of aspirin and impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials

29 August 2017 (14:18 - 14:36)
Organised by:
Congress Presentation Part of: How to make oral anticoagulation safe Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Associate Professor Marco Proietti

University of Milan, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
State of the Art: oral anticoagulation in the challenging patient
Professor P. Kirchhof (Hamburg, DE)
Slides Video
Presentation thumbnail
Increased bleeding events in patients co-administered rivaroxaban and either cyp3A4 or p-gp inhibitors
Doctor J. Michel (Austin, US)
Abstract Slides Video
Presentation thumbnail
Clinical determinants of time in therapeutic range and the role of SAMe-TT2R2 score in atrial fibrillation patients receiving oral anticoagulation: data from FANTASIIA registry.
Doctor M. Esteve Pastor (Murcia, ES)
Abstract Slides Video
Presentation thumbnail
The future of oral anticoagulation
Doctor J. Weitz (Hamilton, CA)
Slides Video

Access the full session

Session thumbnail
How to make oral anticoagulation safe

The Event

Event poster

ESC Congress 2017

29 August 2017 14:18 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources